<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Another Voice Heard in the Genzyme-Bioenvision Takeover Debate: Elliot Associates is “Extremely Dissatisfied”</title>
	<atom:link href="http://www.xconomy.com/boston/2007/09/06/another-voice-heard-in-the-genzyme-bioenvision-takeover-debate-elliot-associates-is-extremely-dissatisfied/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2007/09/06/another-voice-heard-in-the-genzyme-bioenvision-takeover-debate-elliot-associates-is-extremely-dissatisfied/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 09:14:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Andrew Koyfman</title>
		<link>http://www.xconomy.com/boston/2007/09/06/another-voice-heard-in-the-genzyme-bioenvision-takeover-debate-elliot-associates-is-extremely-dissatisfied/comment-page-1/#comment-872</link>
		<dc:creator>Andrew Koyfman</dc:creator>
		<pubDate>Thu, 06 Sep 2007 20:18:09 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2007/09/06/another-voice-heard-in-the-genzyme-bioenvision-takeover-debate-elliot-associates-is-extremely-dissatisfied/#comment-872</guid>
		<description>Thank you for helping us improve our product. We changed the settings to be more printer friendly - just select File -&gt; Print... in your browser and you&#039;ll get the better layout. The printout should be under 2 pages for most articles.  To save even more paper, you may want to consider subscribing to our &lt;a href=&quot;http://www.xconomy.com/rss-feeds&quot; rel=&quot;nofollow&quot;&gt;RSS feed&lt;/a&gt; or &lt;a href=&quot;http://www.xconomy.com/email-updates/&quot; rel=&quot;nofollow&quot;&gt; email newsletter&lt;/a&gt;.  Both have just the article text, without the sidebar or user comments. </description>
		<content:encoded><![CDATA[<p>Thank you for helping us improve our product. We changed the settings to be more printer friendly – just select File -&gt; Print… in your browser and you’ll get the better layout. The printout should be under 2 pages for most articles.  To save even more paper, you may want to consider subscribing to our <a href="http://www.xconomy.com/rss-feeds" rel="nofollow">RSS feed</a> or <a href="http://www.xconomy.com/email-updates/" rel="nofollow"> email newsletter</a>.  Both have just the article text, without the sidebar or user comments.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dice K</title>
		<link>http://www.xconomy.com/boston/2007/09/06/another-voice-heard-in-the-genzyme-bioenvision-takeover-debate-elliot-associates-is-extremely-dissatisfied/comment-page-1/#comment-869</link>
		<dc:creator>Dice K</dc:creator>
		<pubDate>Thu, 06 Sep 2007 19:35:50 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2007/09/06/another-voice-heard-in-the-genzyme-bioenvision-takeover-debate-elliot-associates-is-extremely-dissatisfied/#comment-869</guid>
		<description>Any chance we could get a print friendly version of your articles -each article prints at about 7 pages. Not good for reading on the T. I suppose I am a dinosaur and that I should be using my iPhone!</description>
		<content:encoded><![CDATA[<p>Any chance we could get a print friendly version of your articles -each article prints at about 7 pages. Not good for reading on the T. I suppose I am a dinosaur and that I should be using my iPhone!</p>
]]></content:encoded>
	</item>
</channel>
</rss>

